Wedbush Initiates Blueprint Medicines At Outperform, Calls It A 'Template For Targeted Therapies'
May 26, 2015 at 14:40 PM EDT
Wedbush initiated coverage on Blueprint Medicines Corp (NASDAQ: BPMC) Friday with an Outperform rating and $41 price ...